Effect of half the standard dose of Mao-bushi-saishin-to in two MRSA patients and one decubitus ulcer patient.
Kamei
T
T
Nagura
S
S
Toriumi
Y
Y
Kumano
H
H
Kondoh
T
T
Tomioka
H
H
D000368:Aged; D000369:Aged, 80 and over; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D004365:Drugs, Chinese Herbal / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D016106:Methicillin Resistance; D010608:Pharyngeal Diseases / Q000188:drug therapy; D011023:Pneumonia, Staphylococcal / Q000188:drug therapy; D003668:Pressure Ulcer / Q000188:drug therapy*; D012445:Sacrococcygeal Region; D013203:Staphylococcal Infections / Q000188:drug therapy* / Q000382:microbiology; D013211:Staphylococcus aureus / Q000187:drug effects
D000900:Anti-Bacterial Agents; D000893:Anti-Inflammatory Agents; D004365:Drugs, Chinese Herbal; C119422:mao-bushi-saishin-to